Nanotechnology in Engineering and Medicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 2932
Special Issue Editor
Interests: molecular mechanisms of pain signaling and nociception; mechanisms of browning of white adipose tissue; mitochondrial quality control in adipose tissues and neurons—in physiology and pathology; role of TRP channels and PIP2-rich lipid microdomains in neurodegenerative and neuromuscular diseases; therapeutic potentials of botulinum neurotoxins; neuropharmaceutics—magnetic nanoparticles for site-specific targeted drug delivery to PNS and CNS
Special Issue Information
Dear Colleagues,
Nanotechnology is an exciting area in science, which has many applications in engineering and medicine. Nanoparticle based systems are emerging as a powerful tool for engineering applications like nanomachining and drug therapy for treating diseases like cancer, neuropathic pain, spot-fat reduction, and cardiovascular diseases. Nanoparticles are also widely used in Polymers are widely employed in TDD approaches for successful delivery to target tissues and to ensure optimal drug delivery for the desired period of time.
The aim of this Special Issue is to cover the cutting-edge research activities and recent research advancements in the area of nanotechnology in engineering and medicine.Dr. Baskaran Thyagarajan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- nanomaterials
- pharmaceutical engineering
- tissue targeting
- nanomachining
- drug development and therapeutics
